SCHEMBL28301561

SCHEMBL28301561

C1CCCCCCCCCCCCCCCCC1.C=CC(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.35
ALDH1A1 P00352 5/20 0.34
TP53 P04637 3/20 0.34
HIF1A Q16665 3/20 0.34
CYP3A4 P08684 2/20 0.34
HPGD P15428 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPK1 P28482 1/20 0.34
DGAT1 O75907 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GAA P10253 1/20 0.33
THRB P10828 2/20 0.32
EPHX1 P07099 2/20 0.32
CTSK P43235 1/20 0.32
USP2 O75604 1/20 0.31
THRA P10827 1/20 0.31
BTK Q06187 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27812762 1.00 TSHR (0.35) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL28113226 1.00 TSHR (0.35) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL28310174 1.00 TSHR (0.35) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL28201762 1.00 TSHR (0.35) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL28291756 1.00 TSHR (0.35) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL28839099 1.00 TSHR (0.35) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL28266672 1.00 TSHR (0.35) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL28856602 1.00 TSHR (0.35) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL28175176 1.00 TSHR (0.35) TSHRALDH1A1TP53HIF1ACYP3A4
SCHEMBL28176144 1.00 TSHR (0.35) TSHRALDH1A1TP53HIF1ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110267659-A Compositions and methods for treating CDK4/6 mediated cancers 西奈山伊坎医学院 2019-09-20 CN disclosed
CN-110240629-A Protein degradation targets BCR-ABL compound and its antitumor application thereof 上海科技大学 2019-09-17 CN disclosed
CN-109912655-A Alk protein degradation agent and its antitumor application thereof 上海科技大学 2019-06-21 CN disclosed
CN-109475528-A Bifunctional molecules for EGFR degradation and methods of use 达纳-法伯癌症研究所股份有限公司 2019-03-15 CN disclosed